Imugene Limited (IMU.AX)
AUD 0.04
(-5.26%)
AUD 0.04
(-5.26%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 151.39 Million AUD | -23.17% |
| 2023 | 197.06 Million AUD | 33.51% |
| 2022 | 147.6 Million AUD | 105.55% |
| 2021 | 71.8 Million AUD | 10.13% |
| 2020 | 65.2 Million AUD | 111.85% |
| 2019 | 30.77 Million AUD | 81.97% |
| 2018 | 16.91 Million AUD | 33.42% |
| 2017 | 12.67 Million AUD | 32.95% |
| 2016 | 9.53 Million AUD | 4.62% |
| 2015 | 9.11 Million AUD | 5.6% |
| 2014 | 8.63 Million AUD | 233.97% |
| 2013 | 2.58 Million AUD | 96.03% |
| 2012 | 1.31 Million AUD | -71.87% |
| 2011 | 4.68 Million AUD | 14.36% |
| 2010 | 4.09 Million AUD | -28.88% |
| 2009 | 5.76 Million AUD | 11.61% |
| 2008 | 5.16 Million AUD | -1.84% |
| 2007 | 5.26 Million AUD | -27.63% |
| 2006 | 7.26 Million AUD | -19.81% |
| 2005 | 9.06 Million AUD | 50.67% |
| 2004 | 6.01 Million AUD | -26.13% |
| 2003 | 8.14 Million AUD | 864.49% |
| 2002 | 844.39 Thousand AUD | -65.4% |
| 2001 | 2.44 Million AUD | -33.72% |
| 2000 | 3.68 Million AUD | -46.58% |
| 1999 | 6.89 Million AUD | -12.65% |
| 1998 | 7.89 Million AUD | -9.23% |
| 1997 | 8.69 Million AUD | -6.01% |
| 1996 | 9.24 Million AUD | -22.45% |
| 1995 | 11.92 Million AUD | 5.42% |
| 1994 | 11.31 Million AUD | 98.54% |
| 1993 | 5.69 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 230.42 Million AUD | 0.0% |
| 2024 FY | 151.39 Million AUD | -23.17% |
| 2024 Q4 | 151.39 Million AUD | 0.0% |
| 2023 Q2 | 212.54 Million AUD | 0.0% |
| 2023 Q4 | 197.06 Million AUD | 0.0% |
| 2023 FY | 197.06 Million AUD | 33.51% |
| 2022 FY | 147.6 Million AUD | 105.55% |
| 2022 Q2 | 159.45 Million AUD | 0.0% |
| 2022 Q4 | 147.6 Million AUD | 0.0% |
| 2021 FY | 71.8 Million AUD | 10.13% |
| 2021 Q2 | 67.81 Million AUD | 0.0% |
| 2021 Q4 | 71.8 Million AUD | 0.0% |
| 2020 FY | 65.2 Million AUD | 111.85% |
| 2020 Q4 | 65.2 Million AUD | 0.0% |
| 2020 Q2 | 70.66 Million AUD | 0.0% |
| 2019 FY | 30.77 Million AUD | 81.97% |
| 2019 Q4 | 30.77 Million AUD | 0.0% |
| 2019 Q2 | 33.61 Million AUD | 0.0% |
| 2018 Q2 | 19.45 Million AUD | 0.0% |
| 2018 FY | 16.91 Million AUD | 33.42% |
| 2018 Q4 | 16.91 Million AUD | 0.0% |
| 2017 FY | 12.67 Million AUD | 32.95% |
| 2017 Q4 | 12.67 Million AUD | 0.0% |
| 2017 Q2 | 11.27 Million AUD | 0.0% |
| 2016 Q4 | 9.53 Million AUD | 0.0% |
| 2016 FY | 9.53 Million AUD | 4.62% |
| 2016 Q2 | 10.81 Million AUD | 0.0% |
| 2015 Q2 | 10.55 Million AUD | 0.0% |
| 2015 FY | 9.11 Million AUD | 5.6% |
| 2015 Q4 | 9.11 Million AUD | 0.0% |
| 2014 Q2 | 9.91 Million AUD | 0.0% |
| 2014 FY | 8.63 Million AUD | 233.97% |
| 2014 Q4 | 8.63 Million AUD | 0.0% |
| 2013 Q2 | 2.62 Million AUD | 0.0% |
| 2013 Q4 | 2.58 Million AUD | 0.0% |
| 2013 FY | 2.58 Million AUD | 96.03% |
| 2013 Q1 | 2.62 Million AUD | 98.76% |
| 2013 Q3 | 2.58 Million AUD | -1.37% |
| 2012 Q4 | 1.31 Million AUD | 0.0% |
| 2012 FY | 1.31 Million AUD | -71.87% |
| 2011 Q4 | 4.68 Million AUD | 0.0% |
| 2011 FY | 4.68 Million AUD | 14.36% |
| 2010 FY | 4.09 Million AUD | -28.88% |
| 2010 Q4 | 4.09 Million AUD | 0.0% |
| 2009 FY | 5.76 Million AUD | 11.61% |
| 2009 Q4 | 5.76 Million AUD | 0.0% |
| 2008 FY | 5.16 Million AUD | -1.84% |
| 2008 Q4 | 5.16 Million AUD | 0.0% |
| 2007 FY | 5.26 Million AUD | -27.63% |
| 2007 Q4 | 5.26 Million AUD | 0.0% |
| 2006 FY | 7.26 Million AUD | -19.81% |
| 2006 Q4 | 7.26 Million AUD | 0.0% |
| 2005 FY | 9.06 Million AUD | 50.67% |
| 2005 Q4 | 9.06 Million AUD | 0.0% |
| 2004 Q4 | 6.01 Million AUD | 0.0% |
| 2004 FY | 6.01 Million AUD | -26.13% |
| 2003 FY | 8.14 Million AUD | 864.49% |
| 2003 Q4 | 8.14 Million AUD | 0.0% |
| 2002 Q4 | 844.39 Thousand AUD | 0.0% |
| 2002 FY | 844.39 Thousand AUD | -65.4% |
| 2001 Q4 | 2.44 Million AUD | 0.0% |
| 2001 FY | 2.44 Million AUD | -33.72% |
| 2000 Q4 | 3.68 Million AUD | 0.0% |
| 2000 FY | 3.68 Million AUD | -46.58% |
| 1999 Q4 | 6.89 Million AUD | 0.0% |
| 1999 FY | 6.89 Million AUD | -12.65% |
| 1998 FY | 7.89 Million AUD | -9.23% |
| 1997 Q4 | 8.69 Million AUD | 0.0% |
| 1997 FY | 8.69 Million AUD | -6.01% |
| 1996 FY | 9.24 Million AUD | -22.45% |
| 1995 FY | 11.92 Million AUD | 5.42% |
| 1994 FY | 11.31 Million AUD | 98.54% |
| 1993 FY | 5.69 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 25.55 Million AUD | -492.509% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -8958.025% |
| Zelira Therapeutics Limited | 5.18 Million AUD | -2820.811% |
| Biome Australia Limited | 8.27 Million AUD | -1729.185% |
| Patrys Limited | 4.16 Million AUD | -3537.989% |
| Orthocell Limited | 26.61 Million AUD | -468.839% |
| Noxopharm Limited | 6.78 Million AUD | -2131.769% |
| PYC Therapeutics Limited | 91.23 Million AUD | -65.936% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | -891.268% |
| Prescient Therapeutics Limited | 20.39 Million AUD | -642.406% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | -1292.149% |
| Cynata Therapeutics Limited | 8.38 Million AUD | -1704.871% |
| CSL Limited | 56.93 Billion AUD | 99.734% |
| Arovella Therapeutics Limited | 13.28 Million AUD | -1039.642% |
| Bio-Gene Technology Limited | 3.15 Million AUD | -4691.692% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 34.495% |
| Starpharma Holdings Limited | 36.81 Million AUD | -311.251% |
| Nanollose Limited | 241.95 Thousand AUD | -62473.751% |
| Memphasys Limited | 12.43 Million AUD | -1117.989% |
| Invex Therapeutics Ltd | 6.12 Million AUD | -2373.8% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -2685.161% |
| Amplia Therapeutics Limited | 14.84 Million AUD | -919.85% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | -34.618% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -5803.667% |
| Race Oncology Limited | 20.22 Million AUD | -648.435% |
| Nyrada Inc. | 5.9 Million AUD | -2462.91% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 61.989% |
| Dimerix Limited | 32.07 Million AUD | -371.96% |
| PharmAust Limited | 11.12 Million AUD | -1260.898% |
| Immutep Limited | 147.44 Million AUD | -2.678% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 2.09% |
| Alterity Therapeutics Limited | 19.22 Million AUD | -687.556% |
| BTC Health Limited | 5.14 Million AUD | -2840.445% |
| Acrux Limited | 8.96 Million AUD | -1589.142% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 38.945% |
| Biotron Limited | 493.47 Thousand AUD | -30579.874% |
| Tissue Repair Ltd | 19.38 Million AUD | -680.821% |
| AdAlta Limited | 5.57 Million AUD | -2616.63% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | -110.169% |
| Hexima Limited | 2.26 Million AUD | -6572.435% |
| AnteoTech Limited | 9.38 Million AUD | -1513.846% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | -452.74% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | -2276.876% |
| Avecho Biotechnology Limited | 7.31 Million AUD | -1968.471% |
| Actinogen Medical Limited | 21.31 Million AUD | -610.392% |
| Immuron Limited | 15.54 Million AUD | -873.621% |
| Argenica Therapeutics Limited | 16.37 Million AUD | -824.423% |